Atom Investors LP Pmv Pharmaceuticals, Inc. Transaction History

Atom Investors LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$1.51 - $3.12 $25,947 - $53,614	17,184 Added 41.85%	58,249 $99,000
Q4 2023 Feb 14, 2024	BUY	$1.23 - $6.6 $50,509 - $271,029	41,065 New	41,065 $127,000
Q4 2021 Feb 14, 2022	SELL	$19.99 - $30.24 $543,708 - $822,497	-27,199 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.84 - $36.58 $1.77 Million - $2.41 Million	-65,814 Reduced 70.76%	27,199 $811,000
Q2 2021 Aug 16, 2021	BUY	$28.01 - $36.01 $2.61 Million - $3.35 Million	93,013 New	93,013 $3.18 Million

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.